LINC02133

Across TCGA pan-cancer cohorts, LINC02133 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02133’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02133 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02133 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

HNSC, LUAD, and ESCA are the cancer types where LINC02133 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02133 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.062	<.001	12	view →
LUAD	All	All	+0.332	<.001	6	view →
ESCA	All	II,III,IV	+0.025	.037	2	view →
PRAD	All	All	+0.022	.004	2	view →
KIRP	Male	All	−0.015	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02133–HNSC

Open the HNSC breakdown →